Skip to content
Trial Eligibility
Menu

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

NCT04169542

This study is recruiting at 4 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on well-being). The goal of this study is to collect information about financial costs patients may have as a result of surgical treatment for cancer with or without breast reconstruction and to learn if COVID-19 affects patient costs of breast reconstruction.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Breast Ductal Carcinoma In Situ
  • COVID-19 Infection
  • Hereditary Breast Carcinoma
  • Invasive Breast Carcinoma

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
Female
Healthy volunteers
Not accepted
Sponsor
M.D. Anderson Cancer Center
Last updated on ClinicalTrials.gov
October 7, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 4

  • MD Anderson in The Woodlands · Conroe, TX
  • M D Anderson Cancer Center · Houston, TX
  • MD Anderson League City · League City, TX
  • MD Anderson in Sugar Land · Sugar Land, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.